Disease-Specific as Well as Generic Quality of Life Is Widely Impacted in Autoimmune Hypothyroidism and Improves during the First Six Months of Levothyroxine Therapy
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hypothyroidism is often diagnosed, and subsequently treated, due to health-related quality of life (HRQL) issues. However, HRQL following treatment has never previously been assessed in longitudinal descriptive studies using validated instruments. OBJECTIVE: To investigate disease-specific (ThyPRO) and generic (SF-36) HRQL, following levothyroxine therapy in patients with hypothyroidism due to autoimmune thyroiditis. METHODS: This prospective cohort study was set at endocrine outpatient clinics at two Danish university hospitals. Seventy-eight consecutive patients were enrolled and completed HRQL questionnaires before, six weeks, and six months after initiation of levothyroxine therapy. Normative ThyPRO (n = 739) and SF-36 (n = 6,638) data were available for comparison and changes in HRQL following treatment were estimated and quantified. RESULTS: Prior to treatment, all ThyPRO scales were significantly impacted (p<0.0001), compared to the general population sample. The same was observed for seven of eight SF-36 scales, the exception being Bodily Pain. Tiredness (ThyPRO) and Vitality (SF-36) were the most markedly impacted scales. After six weeks of treatment, nine of thirteen ThyPRO scales had significantly improved. ThyPRO improvements were consistent at six months, where five of eight SF-36 scales had also significantly improved, but deficits persisted for a subset of both ThyPRO and SF-36 scales. CONCLUSIONS: In this population of hypothyroid patients, HRQL was widely affected before treatment, with tiredness as the cardinal impairment according to both ThyPRO and SF-36. Many aspects of HRQL improved during the first six months of LT4 therapy, but full recovery was not obtained. Our results may help clinicians inform patients about expected clinical treatment effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A ThyPRO Composite scale score of 32 or TSQ >4 has been shown to represent a score that signifies a worse QoL, which is sufficiently above the mean score in patients with hypothyroidism (32).”
From Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design (2023) · cites this paper as [32]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When patients with hypothyroidism were compared with the general population, tiredness was one of the parameters that showed the most difference between the populations, with a large effect size (66).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [66]
The cited source says what the claim attributes to it.
In the citing paper
“In an uncontrolled prospective study of the initiation of LT4 therapy for mild hypothyroidism (TSH values 5.5–12.2 mIU/L), it was also one of the scales that showed the most improvement with treatment (66).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [66]
The cited source says what the claim attributes to it.
In the citing paper
“The cognitive complaints scale, although different from the general population, did not improve significantly with 6 months of LT4 treatment.”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [66]
The cited source says what the claim attributes to it.
In the citing paper
“When patients with hypothyroidism were compared with the general population, tiredness was one of the parameters that showed the most difference between the populations, with a large effect size [66].”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [66]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033 · cited 1×
“Measurement properties have been well-described for the most widely used generic instrument, SF-36 [11,12], while some currently available disease-specific instruments (4,6) have undergone initial validation in hypothyroid patients [6,13,14].”
MethodCohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Measuring Health-Related Quality of Life
Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-8-199304150-00009 · Cited by 3,958
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824 · cited 1×
“This is well in line with the Colorado thyroid disease prevalence study, where 40% of patients taking thyroid medication had abnormal TSH levels [30].”
ResultThe impact of patient-centered care on outcomes.
Stewart, M., Brown, J. B., DONNER, A. P., McWhinney, I. R., Oates, J., Weston, W. W., & Jordan, J. (2000) · PubMed · Cited by 2,508
Patient reported outcome measures could help transform healthcare
Black, N. (2013) · BMJ · doi:10.1136/bmj.f167 · Cited by 1,960
Biological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272 · cited 1×
“HRQL assessment could do so by contributing, in a positive manner, to the overall therapeutic context [37].”
BackgroundSaravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514
Wekking, E. M., Appelhof, B. C., Fliers, E., Schene, A. H., Huyser, J., Tijssen, J. G. P., & Wiersinga, W. M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02025 · Cited by 299
Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review
Contopoulos-Ioannidis, D. G., Karvouni, A., Kouri, I., & Ioannidis, J. P. A. (2009) · BMJ · doi:10.1136/bmj.a3006 · Cited by 249 · cited 1×
“Measurement properties have been well-described for the most widely used generic instrument, SF-36 [11,12], while some currently available disease-specific instruments (4,6) have undergone initial validation in hypothyroid patients [6,13,14].”
MethodPsychiatric and cognitive manifestations of hypothyroidism
Samuels, M. H. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000089 · Cited by 220 · cited 1×
“However, it has been suggested that persisting cognitive complaints, even in patients with subclinical hypothyroidism (the majority of our participants), are most likely an independent entity requiring separate evaluation [27].”
BackgroundValidity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO
Watt, T., Hegedüs, L., Groenvold, M., Bjorner, J. B., Rasmussen, Å. K., Bonnema, S. J., & Feldt-Rasmussen, U. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0521 · Cited by 210
Self-citationEpidemiology of subtypes of hypothyroidism in Denmark.
Carlé, A., Laurberg, P., Pedersen, I. B., Knudsen, N., Perrild, H., Ovesen, L., Rasmussen, L. B., & Jorgensen, T. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02068 · Cited by 195
Tzelepis, F., Sanson-Fisher, R., Zucca, A., & Fradgley, E. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s81975 · Cited by 180
Watt, T., Cramon, P., Hegedüs, L., Bjorner, J. B., Bonnema, S. J., Rasmussen, Å. K., Feldt-Rasmussen, U., & Groenvold, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1322 · Cited by 152 · cited 3×
“A subset of the data has previously been used for a methodological evaluation of the responsiveness of the ThyPRO questionnaire [21].”
MethodSelf-citationThe study design and characteristics of the Danish national health interview surveys
Ekholm, O., Hesse, U., Davidsen, M., & Kjøller, M. (2009) · Scandinavian Journal of Public Health · doi:10.1177/1403494809341095 · Cited by 146 · cited 1×
“SF-36 data from the Danish general population were derived from the Danish Health Interview Survey in 2005, as described elsewhere [23,24].”
MethodSelf-citationDayan, C. M., & Panicker, V. (2013) · European Thyroid Journal · doi:10.1159/000353777 · Cited by 142 · cited 2×
“It constitutes the primary outcome in our on-going randomized controlled trial of selenium supplementation in AIT [39], and can be put to ideal use in future trials investigating various formulations of LT4 and/or combinations with liothyronine [3] or placebo-controlled trials in subclinical hypothyroidism [28].”
BackgroundBülow Pedersen, I., Laurberg, P., Knudsen, N., Jørgensen, T., Perrild, H., Ovesen, L., & Rasmussen, L. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0732 · Cited by 142
Development of a Short Version of the Thyroid-Related Patient-Reported Outcome ThyPRO
Watt, T., Bjorner, J. B., Groenvold, M., Cramon, P., Winther, K. H., Hegedüs, L., Bonnema, S. J., Rasmussen, Å. K., Ware, J. E., & Feldt-Rasmussen, U. (2015) · Thyroid · doi:10.1089/thy.2015.0209 · Cited by 132 · cited 1×
“To advance its applicability, both in clinical practice and research, we have recently developed a short version of ThyPRO [38].”
Self-citationThvilum, M., Brandt, F., Almind, D., Christensen, K., Brix, T. H., & Hegedüs, L. (2014) · Thyroid · doi:10.1089/thy.2013.0555 · Cited by 121
Self-citationParadigm shifts in thyroid hormone replacement therapies for hypothyroidism
Wiersinga, W. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.258 · Cited by 114
Watt, T., Bjorner, J. B., Groenvold, M., Rasmussen, Å. K., Bonnema, S. J., Hegedüs, L., & Feldt-Rasmussen, U. (2009) · Quality of Life Research · doi:10.1007/s11136-009-9460-8 · Cited by 112
Self-citationCarlé, A., Pedersen, I. B., Knudsen, N., Perrild, H., Ovesen, L., & Laurberg, P. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0481 · Cited by 95 · cited 3×
“The wide array of impacts was corroborated in a recent population-based case-control study of newly diagnosed overt AIT, with tiredness being the most frequently reported symptom [26].”
BackgroundThvilum, M., Brandt, F., Almind, D., Christensen, K., Brix, T. H., & Hegedüs, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075789 · Cited by 92
Self-citationWatt, T., Hegedüs, L., Rasmussen, Å. K., Groenvold, M., Bonnema, S. J., Bjorner, J. B., & Feldt-Rasmussen, U. (2007) · Thyroid · doi:10.1089/thy.2007.0069 · Cited by 89
Self-citationWatt, T., Rasmussen, Å. K., Grøenvold, M., Bjørner, J. B., Watt, S. K., Bonnema, S. J., Hegedűs, L. D., & Feldt‐Rasmussen, U. (2008) · Quality of Life Research · doi:10.1007/s11136-008-9364-z · Cited by 84
Self-citationThvilum, M., Brandt, F., Almind, D., Christensen, K., Hegedüs, L., & Brix, T. H. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3375 · Cited by 83
Self-citationWinther, K. H., Watt, T., Bjørner, J. B., Cramon, P., Feldt-Rasmussen, U., Gluud, C., Gram, J., Groenvold, M., Hegedüs, L., Knudsen, N., et al. (2014) · Trials · doi:10.1186/1745-6215-15-115 · Cited by 83 · cited 10×
“In a recent study both depressive symptoms and sexual dysfunction were related to subclinical hypothyroidism in female patients with AIT [29].”
BackgroundInfluentialSelf-citationDesign of New Questionnaires to Measure Quality of Life and Treatment Satisfaction in Hypothyroidism
McMillan, C. V., Bradley, C., Woodcock, A., Razvi, S., & Weaver, J. U. (2004) · Thyroid · doi:10.1089/thy.2004.14.916 · Cited by 75
Quality of life in patients with primary hypothyroidism related to BMI
Kelderman-Bolk, N., Visser, T. J., Tijssen, J. P., & Berghout, A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0395 · Cited by 70
McMillan, C., Bradley, C., Razvi, S., & Weaver, J. U. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00232.x · Cited by 66 · cited 1×
“Measurement properties have been well-described for the most widely used generic instrument, SF-36 [11,12], while some currently available disease-specific instruments (4,6) have undergone initial validation in hypothyroid patients [6,13,14].”
MethodCramon, P., Bonnema, S. J., Bjorner, J. B., Ekholm, O., Feldt-Rasmussen, U., Frendl, D. M., Groenvold, M., Hegedüs, L., Rasmussen, Å. K., & Watt, T. (2015) · Thyroid · doi:10.1089/thy.2014.0433 · Cited by 62 · cited 1×
“SF-36 data from the Danish general population were derived from the Danish Health Interview Survey in 2005, as described elsewhere [23,24].”
MethodSelf-citationKrysiak, R., Drosdzol‐Cop, A., Skrzypulec‐Plinta, V., & Okopien, B. (2016) · Clinical Endocrinology · doi:10.1111/cen.12956 · Cited by 61 · cited 10×
“In a recent study both depressive symptoms and sexual dysfunction were related to subclinical hypothyroidism in female patients with AIT [29].”
BackgroundInfluentialConfirmatory factor analysis of the thyroid-related quality of life questionnaire ThyPRO
Watt, T., Groenvold, M., Deng, N., Gandek, B., Feldt-Rasmussen, U., Rasmussen, Å. K., Hegedüs, L., Bonnema, S. J., & Bjorner, J. B. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0126-z · Cited by 46
Self-citationQuinque, E. M., Villringer, A., Kratzsch, J., & Karger, S. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-68 · Cited by 36 · cited 1×
“Measurement properties have been well-described for the most widely used generic instrument, SF-36 [11,12], while some currently available disease-specific instruments (4,6) have undergone initial validation in hypothyroid patients [6,13,14].”
MethodWatt, T., Groenvold, M., Hegedüs, L., Bonnema, S. J., Rasmussen, Å. K., Feldt-Rasmussen, U., & Bjorner, J. B. (2014) · Quality of Life Research · doi:10.1007/s11136-013-0462-1 · Cited by 30
Self-citationAssessing quality of life in clinical trials
Hoop, R., Zbrozek, A., McPherson, M. A., & Malone, N. (1992) · Controlled Clinical Trials · doi:10.1016/0197-2456(92)90127-l · Cited by 23
Cited by
Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism
Stott, D. J., Rodondi, N., Kearney, P. M., Ford, I., Westendorp, R. G. J., Mooijaart, S. P., Sattar, N., Aubert, C. E., Aujesky, D., Bauer, D. C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1603825 · Cited by 490
Self-citationEndocrine toxicities of immune checkpoint inhibitors
Wright, J. J., Powers, A. C., & Johnson, D. B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00484-3 · Cited by 441
Chaker, L., Razvi, S., Bensenor, I. M., Azizi, F., Pearce, E. N., & Peeters, R. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00357-7 · Cited by 330
Selenium in thyroid disorders—essential knowledge for clinicians
Winther, K. H., Rayman, M. P., Bonnema, S. J., & Hegedüs, L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0311-6 · Cited by 288
Self-citationJonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0720 · Cited by 172
“When patients with hypothyroidism were compared with the general population, tiredness was one of the parameters that showed the most difference between the populations, with a large effect size (66).”
InfluentialSelf-citation
Metadata
- Authors
- Winther, K. H., Cramon, P., Watt, T., Bjorner, J. B., Ekholm, O., Feldt-Rasmussen, U., Groenvold, M., Rasmussen, Å. K., Hegedüs, L., & Bonnema, S. J.
- Affiliations
- University of Southern Denmark (DK)
- Copenhagen University Hospital (DK)
- Corresponding author
- Winther, Kristian Hillert
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-06-03
- Volume
- 11
- Issue
- 6
- Pages
- e0156925
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4892657
- OpenAlex
- W2410385350
- Cited by
- 152
- References
- 42
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 13 · 2023: 12 · 2022: 21 · 2021: 20 · 2020: 15 · 2019: 15 · 2018: 18 · 2017: 15 · 2016: 3
- FWCI
- 17.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by-sa)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Novo Nordisk
- Odense Universitetshospital
- Rigshospitalet
- Syddansk Universitet
- Novo Nordisk Fonden (NNF15OC0014622)
- Forsknings- og Innovationsstyrelsen
- Danish Agency for Science and Higher Education
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- autoimmune hypothyroidism, autoimmune thyroiditis, health-related quality of life, levothyroxine therapy, SF-36, fatigue, vitality, disease-specific quality of life, generic quality of life, treatment outcomes
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Hormones, Humans, Male, Middle Aged, Prospective Studies, Psychometrics, Quality of Life, Surveys and Questionnaires, Thyroiditis, Autoimmune, Thyroxine, Time Factors, Hashimoto Disease, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.